https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-degradation-of-btk-using-compound-of-formula-a-2/
Discover how Nurix Therapeutics' patented compounds target and degrade BTK, offering groundbreaking treatments for cancer and autoimmune diseases. Explore the...
meta titlenurixtherapeuticsincpatent
https://www.nurixtx.com/
Jan 11, 2025 - Discover Nurix Therapeutic's targeted protein degradation platform, combining degraders and DACs to transform cancer and autoimmune disease treatment.
nurixmedicinesdisease
https://www.hl.co.uk/shares/shares-search-results/n/nurix-therapeutics-inc-usd0.001/director-deals
Recent director deals and the 5 most significant trades from the last 3 months for Nurix Therapeutics Inc.
directorsharedealingsnurixtherapeutics
https://theorg.com/org/nurix-1
Nurix is here to revolutionise customer engagement with intelligent, adaptive AI solutions that drive efficiency, satisfaction, and growth. Most established...
nurixorg
https://www.pharmaceutical-technology.com/data-insights/zelebrudomide-nurix-therapeutics-net-present-value/
Zelebrudomide is a small molecule commercialized by Nurix Therapeutics, with a leading Phase I program in Primary CNS Lymphoma.
net present valuerisk adjustedcurrentvaluation